a.

tests to demonstrate that any assumptions made within the internal model are appropriate and do not underestimate or overestimate the risk;

b.

in addition to regulatory back-testing of programmes, Authorised Persons should carry out their own internal model validation tests, including back-testing, in relation to the risks and structures of their portfolios; and

c.

the use of hypothetical portfolios to ensure that the internal model is able to account for particular structural features that may arise, for example material basis risks and concentration risks.

20.

The Authorised Person should perform back-testing on both actual and hypothetical changes in the portfolio's value.